US5840733A
(en)
|
1996-07-01 |
1998-11-24 |
Redcell, Canada, Inc. |
Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
|
US5786153A
(en)
*
|
1996-09-12 |
1998-07-28 |
Chiron Diagnostics Corporation |
Prevention of probe coating on automated analyzers using a non-denaturing surfactant
|
WO1998053828A1
(fr)
*
|
1997-05-27 |
1998-12-03 |
Senju Pharmaceutical Co., Ltd. |
Preparations aqueuses contenant de l'israpafant
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6949816B2
(en)
|
2003-04-21 |
2005-09-27 |
Motorola, Inc. |
Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
FR2793412B1
(fr)
*
|
1999-05-11 |
2001-07-27 |
Synthelabo |
Formulations galeniques d'argatroban pour administration sous-cutanee
|
KR100399373B1
(ko)
*
|
2000-12-20 |
2003-09-26 |
주식회사 아이센스 |
콜란산 고리를 포함하는 디글라이콜릭 디아마이드 유도체,그의 제조방법 및 용도
|
US6560471B1
(en)
|
2001-01-02 |
2003-05-06 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
EP1397068A2
(en)
|
2001-04-02 |
2004-03-17 |
Therasense, Inc. |
Blood glucose tracking apparatus and methods
|
US6984395B2
(en)
*
|
2001-04-11 |
2006-01-10 |
Qlt, Inc. |
Drug delivery system for hydrophobic drugs
|
US8771183B2
(en)
|
2004-02-17 |
2014-07-08 |
Abbott Diabetes Care Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
US7811231B2
(en)
|
2002-12-31 |
2010-10-12 |
Abbott Diabetes Care Inc. |
Continuous glucose monitoring system and methods of use
|
TW200505422A
(en)
*
|
2003-03-20 |
2005-02-16 |
Mitsubishi Pharma Corp |
Pharmaceutical preparations containing arginine amides
|
US8066639B2
(en)
|
2003-06-10 |
2011-11-29 |
Abbott Diabetes Care Inc. |
Glucose measuring device for use in personal area network
|
US8112240B2
(en)
|
2005-04-29 |
2012-02-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing leak detection in data monitoring and management systems
|
MX2008002177A
(es)
*
|
2005-09-01 |
2008-04-22 |
Baxter Healthcare Sa |
Formulacion de argatroban.
|
US7766829B2
(en)
|
2005-11-04 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and system for providing basal profile modification in analyte monitoring and management systems
|
US8226891B2
(en)
|
2006-03-31 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods therefor
|
US7620438B2
(en)
|
2006-03-31 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for powering an electronic device
|
WO2007143225A2
(en)
|
2006-06-07 |
2007-12-13 |
Abbott Diabetes Care, Inc. |
Analyte monitoring system and method
|
CA2662853C
(en)
*
|
2006-08-31 |
2016-07-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
EP2083823A4
(en)
*
|
2006-09-27 |
2010-01-13 |
Eagle Pharmaceuticals Inc |
ALCOHOL-FREE FORMULATION OF ARGATROBAN
|
US7687516B2
(en)
*
|
2006-09-27 |
2010-03-30 |
Eagle Pharmaceuticals, Inc. |
Alcohol free formulation of argatroban
|
US20100076019A1
(en)
*
|
2006-10-11 |
2010-03-25 |
Eagle Pharmaceuticals, Inc. |
Alcohol free formulation of argatroban
|
US8930203B2
(en)
|
2007-02-18 |
2015-01-06 |
Abbott Diabetes Care Inc. |
Multi-function analyte test device and methods therefor
|
US8732188B2
(en)
|
2007-02-18 |
2014-05-20 |
Abbott Diabetes Care Inc. |
Method and system for providing contextual based medication dosage determination
|
US8123686B2
(en)
|
2007-03-01 |
2012-02-28 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing rolling data in communication systems
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
US8456301B2
(en)
|
2007-05-08 |
2013-06-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8461985B2
(en)
|
2007-05-08 |
2013-06-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US7928850B2
(en)
|
2007-05-08 |
2011-04-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8665091B2
(en)
|
2007-05-08 |
2014-03-04 |
Abbott Diabetes Care Inc. |
Method and device for determining elapsed sensor life
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
US8974827B2
(en)
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
US9233078B2
(en)
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
US7915290B2
(en)
*
|
2008-02-29 |
2011-03-29 |
Baxter International Inc. |
Argatroban formulations and methods for making and using same
|
US20090221637A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Baxter International Inc. |
Solid-state salt argatroban formulations and methods for producing and using the same
|
US8103456B2
(en)
|
2009-01-29 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and device for early signal attenuation detection using blood glucose measurements
|
WO2010127050A1
(en)
|
2009-04-28 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Error detection in critical repeating data in a wireless sensor system
|
WO2010138856A1
(en)
|
2009-05-29 |
2010-12-02 |
Abbott Diabetes Care Inc. |
Medical device antenna systems having external antenna configurations
|
WO2011026147A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Analyte signal processing device and methods
|
WO2011026148A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods for managing power and noise
|
US9320461B2
(en)
|
2009-09-29 |
2016-04-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing notification function in analyte monitoring systems
|
CN102366410B
(zh)
*
|
2011-09-14 |
2013-05-29 |
海南灵康制药有限公司 |
一种阿加曲班脂质体注射剂
|
AU2012335830B2
(en)
|
2011-11-07 |
2017-05-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods
|
US9968306B2
(en)
|
2012-09-17 |
2018-05-15 |
Abbott Diabetes Care Inc. |
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
|
US20150034098A1
(en)
|
2013-07-11 |
2015-02-05 |
Aqua Turf International, Inc. |
Air filtration mask with opening front cover
|
DE102014108210A1
(de)
|
2014-06-11 |
2015-12-17 |
Dietrich Gulba |
Rodentizid
|
WO2020231791A1
(en)
*
|
2019-05-10 |
2020-11-19 |
Fordoz Pharma Corp. |
Injectable polymer nanoparticle compositions of antithrombotic agents and methods thereof
|
CN110478471B
(zh)
*
|
2019-09-17 |
2020-04-10 |
鲁南制药集团股份有限公司 |
一种阿加曲班注射液及其制备方法
|
US20230134153A1
(en)
|
2020-07-03 |
2023-05-04 |
Toshiba Mitsubishi-Electric Industrial Systems Corporation |
Uninterruptible power supply system
|
EP4070658A1
(de)
|
2021-04-06 |
2022-10-12 |
BIORoxx GmbH |
Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
|
CN113855635A
(zh)
*
|
2021-10-20 |
2021-12-31 |
陇南市第一人民医院 |
一种阿加曲班注射液脂质体及其制备方法
|